NCT01288183

Brief Summary

The aim of this study is to determine whether a powerful technique of noninvasive brain stimulation, transcranial direct current stimulation (tDCS), could reduce cigarette smoking and constitute a treatment of tobacco addiction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

January 27, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 2, 2011

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

January 26, 2018

Status Verified

January 1, 2018

Enrollment Period

3.9 years

First QC Date

January 27, 2011

Last Update Submit

January 24, 2018

Conditions

Keywords

tobaccosmokingtDCSDLPFC

Outcome Measures

Primary Outcomes (1)

  • Smoking

    Self-reported number of cigarettes smoked each day

    Baseline (three days before starting tDCS regimen) to one-month after

Secondary Outcomes (3)

  • Exhaled carbon monoxide

    Baseline, one-week (after the last tDCS session) and one-month later

  • Craving

    For each of the 10 tDCS sessions: Baseline and 0 hour post-tDCS (immediately after)

  • fMRI brain reactivity during a smoking cue-reactivity task

    Baseline and one-week (after the last tDCS session)

Study Arms (2)

sham tDCS

SHAM COMPARATOR

sham transcranial direct current stimulation The anode (7 x 5 cm) is placed on the right dorsolateral prefrontal cortex. A large cathode (10 x 10cm) is placed on the left occipital region

Procedure: sham tDCS

active tDCS

ACTIVE COMPARATOR

active anodal tDCS over the right dorsolateral prefrontal cortex The anode (7 x 5 cm) is placed on the right dorsolateral prefrontal cortex. A large cathode (10 x 10cm) is placed on the left occipital region Intensity of the stimulation: 2 mA Duration of the stimulation: 20 min 10 sessions, 2 per day

Procedure: active tDCS

Interventions

sham tDCSPROCEDURE

sham condition as delivered by the stimulator "study mode" (2mA during 40s and brief current pulses until the end of the stimulation) 20 minutes, 10 sessions, 2 per day

sham tDCS
active tDCSPROCEDURE

anodal tDCS applied over the right DLPFC 2mA, 20minutes, 10 sessions, 2 per day

active tDCS

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age from 18 to 55 years old
  • Tobacco consumption from 10 to 25 cigarettes, for at least 1 year
  • Strong tobacco dependence at the Fagerstrom Test (score \>= 5)
  • Motivation to quit with a score \>=12 at the Motivation to Quit Smoking Scale (Q-MAT)
  • Informed consent

You may not qualify if:

  • Concomitant Axe I psychiatric disorder according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM IV)
  • Other addictive disorder (DSM IV)
  • No history of smoking cessation drug the previous year
  • Psychotropic treatment
  • Pregnancy or nursing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital le Vinatier

Bron, 69677, France

Location

MeSH Terms

Conditions

Behavior, AddictiveSmoking

Condition Hierarchy (Ancestors)

Compulsive BehaviorImpulsive BehaviorBehavior

Study Officials

  • JEROME BRUNELIN, PhD

    Hopital le Vinatier

    STUDY DIRECTOR
  • Emmanuel POULET, MD, PhD

    Hopital le Vinatier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PUPH

Study Record Dates

First Submitted

January 27, 2011

First Posted

February 2, 2011

Study Start

January 1, 2011

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

January 26, 2018

Record last verified: 2018-01

Locations